Prelude Capital Management’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-147,727
| Closed | -$2.5M | – | 1224 |
|
|
2024
Q4 | $2.5M | Sell |
147,727
-10,334
| -7% | -$201K | 0.16% | 138 |
|
|
2024
Q3 | $3.21M | Buy |
+158,061
| New | +$3.23M | 0.19% | 125 |
|
|
2022
Q3 | – | Sell |
-88,698
| Closed | -$2.84M | – | 1607 |
|
|
2022
Q2 | $2.84M | Sell |
88,698
-168,899
| -66% | -$6.21M | 0.08% | 196 |
|
|
2022
Q1 | $8.11M | Sell |
257,597
-6,391
| -2% | -$200K | 0.23% | 65 |
|
|
2021
Q4 | $8.86M | Sell |
263,988
-71,529
| -21% | -$2.23M | 0.23% | 54 |
|
|
2021
Q3 | $9.75M | Sell |
335,517
-17,712
| -5% | -$573K | 0.25% | 44 |
|
|
2021
Q2 | $12.3M | Buy |
353,229
+5,210
| +1% | +$173K | 0.37% | 32 |
|
|
2021
Q1 | $9.71M | Buy |
348,019
+2,101
| +0.6% | +$55.9K | 0.25% | 42 |
|
|
2020
Q4 | $8.57M | Buy |
+345,918
| New | +$8.23M | 0.22% | 56 |
|
|
2020
Q3 | – | Sell |
-1,950
| Closed | -$30K | – | 1867 |
|
|
2020
Q2 | $30K | Buy |
+1,950
| New | +$24.7K | ﹤0.01% | 1288 |
|
|
2020
Q1 | – | Sell |
-17,775
| Closed | -$322K | – | 1490 |
|
|
2019
Q4 | $322K | Buy |
+17,775
| New | +$295K | 0.01% | 699 |
|
|
2019
Q2 | – | Sell |
-2,024
| Closed | -$75K | – | 1715 |
|
|
2019
Q1 | $75K | Sell |
2,024
-2,218
| -52% | -$80.7K | ﹤0.01% | 1019 |
|
|
2018
Q4 | $120K | Sell |
4,242
-10,349
| -71% | -$327K | 0.01% | 873 |
|
|
2018
Q3 | $575K | Buy |
14,591
+9,580
| +191% | +$419K | 0.03% | 489 |
|
|
2018
Q2 | $222K | Buy |
5,011
+2,233
| +80% | +$111K | 0.01% | 729 |
|
|
2018
Q1 | $135K | Buy |
2,778
+310
| +13% | +$15.5K | 0.01% | 786 |
|
|
2017
Q4 | $124K | Sell |
2,468
-9,642
| -80% | -$505K | 0.01% | 737 |
|
|
2017
Q3 | $613K | Buy |
12,110
+3,410
| +39% | +$161K | 0.06% | 331 |
|
|
2017
Q2 | $330K | Buy |
+8,700
| New | +$343K | 0.03% | 433 |
|
|
2017
Q1 | – | Sell |
-9,045
| Closed | -$200K | – | 1517 |
|
|
2016
Q4 | $200K | Sell |
9,045
-7,979
| -47% | -$164K | 0.02% | 585 |
|
|
2016
Q3 | $272K | Sell |
17,024
-118,732
| -87% | -$1.36M | 0.03% | 472 |
|
|
2016
Q2 | $1.12M | Buy |
135,756
+135,536
| +61,607% | +$1.21M | 0.16% | 152 |
|
|
2016
Q1 | $2K | Hold |
220
| – | – | ﹤0.01% | 1216 |
|
|
2015
Q4 | $1K | Hold |
220
| – | – | ﹤0.01% | 1413 |
|
|
2015
Q3 | $1K | Buy |
+220
| New | +$2.3K | ﹤0.01% | 1440 |
|
Other funds holding CC
AWAM
Prelude Capital Management's CC Position: Q1 2025 in Review
Prelude Capital Management sold out of Chemours (CC) in Q1 2025, closing a stake of 147,727 shares — an estimated $2.5M sold.
Prelude Capital Management first reported a position in CC in Q3 2015 and held it in 25 quarters. The position peaked at $12.3M in Q2 2021. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.
- Prelude Capital Management reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
- Prelude Capital Management sold 147,727 Chemours shares in Q1 2025, an estimated $2.5M.
- Prelude Capital Management first reported a position in Chemours in Q3 2015 and held it in 25 quarters.
- Prelude Capital Management's Chemours position peaked at $12.3M in Q2 2021.
- 419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.